{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:02:15Z","timestamp":1791000135615,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Charles University, Prague"},{"name":"Ministry of Defense, Prague"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jpba.2020.113519","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T13:29:10Z","timestamp":1596288550000},"page":"113519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["In vitro and in vivo metabolism of 3-quinuclidinyl benzilate by high-resolution mass spectrometry"],"prefix":"10.1016","volume":"190","author":[{"given":"Martin","family":"Uher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"M\u017eik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana \u017d\u010f\u00e1rov\u00e1","family":"Karasov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"\u010cechov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al\u017eb\u011bta","family":"Dlabkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Mrkvicov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"Hroch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113519_bib0005","series-title":"Handbook of Toxicology of Chemical Warfare Agents","author":"Liu","year":"2015"},{"key":"10.1016\/j.jpba.2020.113519_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tox.2005.06.011","article-title":"History of chemical and biological warfare agents","volume":"214","author":"Szinicz","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.jpba.2020.113519_bib0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1474-8673.2006.00368.x","article-title":"Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function","volume":"26","author":"Eglen","year":"2006","journal-title":"Auton. Autacoid Pharmacol."},{"key":"10.1016\/j.jpba.2020.113519_bib0020","series-title":"Handbook of Toxicology of Chemical Warfare Agents","author":"Wismer","year":"2015"},{"key":"10.1016\/j.jpba.2020.113519_bib0025","series-title":"Handbook of Toxicology of Chemical Warfare Agents","author":"Fusek","year":"2015"},{"key":"10.1016\/j.jpba.2020.113519_bib0030","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.205.4410.982.a","article-title":"Scientologists obtain potent hallucinogen, QNB","volume":"205","author":"Marshall","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.jpba.2020.113519_bib0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/13623699808409383","article-title":"Surviving the impossible: the long March from Srebrenica. An investigation of the possible use of chemical warfare agents","volume":"14","author":"Hay","year":"1998","journal-title":"Med. Confl. Surviv."},{"key":"10.1016\/j.jpba.2020.113519_bib0040","article-title":"Russia\u2019s Lavrov says Skripals may have been poisoned by substance Russia never made","author":"Ostroukh","year":"2018","journal-title":"Reuters"},{"key":"10.1016\/j.jpba.2020.113519_bib0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.6028\/jres.093.050","article-title":"Determination of 3-Quinuclidinyl benzilate in Urine","volume":"93","author":"Byrd","year":"1988","journal-title":"J. Res. Bur. Stand."},{"key":"10.1016\/j.jpba.2020.113519_bib0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jat\/16.3.182","article-title":"Determination of 3-quinuclidinyl benzilate (QNB) and its major metabolites in urine by isotope dilution gas chromatography\/mass spectrometry","volume":"16","author":"Byrd","year":"1992","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2020.113519_bib0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0021-9673(96)00763-7","article-title":"Application of liquid chromatography-atmospheric pressure chemical ionisation mass spectrometry, and tandem mass spectrometry, to the analysis and identification of degradation products of chemical warfare agents","volume":"759","author":"Black","year":"1997","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2020.113519_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9673(03)00183-3","article-title":"Derivatisation reactions in the chromatographic analysis of chemical warfare agents and their degradation products","volume":"1000","author":"Black","year":"2003","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2020.113519_bib0065","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/dta.2742","article-title":"Simple validated method of LC\u2013MS\/MS determination of BZ agent in rat plasma samples","volume":"12","author":"Herman","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2020.113519_bib0070","series-title":"Chemical Weapons Convention Chemicals Analysis: Sample Collection, Preparation and Analytical Methods","author":"Wils","year":"2005"},{"key":"10.1016\/j.jpba.2020.113519_bib0075","series-title":"In Silico Prediction of Site of Metabolism; Institute of Biomedical Chemistry","author":"Poroikov","year":"2020"},{"key":"10.1016\/j.jpba.2020.113519_bib0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0379-0738(80)90194-2","article-title":"Analytical studies on some nitrogenous hallucinogens","volume":"15","author":"Zaki","year":"1980","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2020.113519_bib0085","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1135\/cccc19742037","article-title":"Azabicyclo compounds. 13. Mass spectra of 4-substituted quinuclidines","volume":"39","author":"Palecek","year":"1974","journal-title":"Collect. Czech. Chem. Commun."},{"key":"10.1016\/j.jpba.2020.113519_bib0090","first-page":"604","article-title":"Some novel eliminations of neutral fragments from ions in mass spectrometry .2. Loss of non-terminal carbon atoms as methyl radicals","volume":"21","author":"Johnstone","year":"1966","journal-title":"Zeitschrift Fur Naturforschung Part a-Astrophysik Physik Und Physikalische Chemie, A"},{"key":"10.1016\/j.jpba.2020.113519_bib0095","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/oms.1210061210","article-title":"Azabicyclo compounds. 9. Study of fragmentation processes of quinuclidine and some of its derivatives","volume":"6","author":"Palecek","year":"1972","journal-title":"Org. Mass Spectrom."},{"key":"10.1016\/j.jpba.2020.113519_bib0100","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1021\/ac9911692","article-title":"Liquid chromatography\/mass spectrometry methods for distinguishing N-oxides from hydroxylated compounds","volume":"72","author":"Ramanathan","year":"2000","journal-title":"Anal. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520314059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520314059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:06:08Z","timestamp":1760000768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708520314059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":20,"alternative-id":["S0731708520314059"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113519","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo metabolism of 3-quinuclidinyl benzilate by high-resolution mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113519"}}